Axe Compute (AGPU) Registration filing summary

Company overview and business model

• Provides high-performance computing infrastructure for AI workloads by sourcing and deploying large-scale GPU capacity for enterprise clients under long-term service agreements.

• Offers both custom infrastructure deployments and rapid access to third-party GPU compute resources, supporting a range of AI and high-performance computing needs.

• Maintains a Strategic Compute Reserve, primarily in ATH tokens, to secure immediate GPU access and generate yield through staking and lending.

• Legacy oncology drug discovery business is being evaluated for strategic alternatives, with current operations limited.

Financial performance and metrics

• Aggregate market value of common stock held by non-affiliates is $79.2 million, based on 10,819,094 shares at $7.32 per share as of June 8, 2026.

• Strategic Compute Reserve includes approximately 6.197 billion ATH tokens valued at $29.1 million as of June 8, 2026.

• Recent 36-month enterprise contract valued at $260 million for dedicated GPU infrastructure.

Use of proceeds and capital allocation

• Net proceeds will be used for general corporate purposes, working capital, funding compute services, infrastructure expansion, and growing the Strategic Compute Reserve.

• May allocate funds for capital expenditures, IP or technology acquisitions, and potential investments or acquisitions in complementary businesses.

• Management has broad discretion over allocation; no binding commitments for acquisitions as of the filing date.